These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31147526)

  • 41. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SHIP1 is targeted by miR-155 in acute myeloid leukemia.
    Xue H; Hua LM; Guo M; Luo JM
    Oncol Rep; 2014 Nov; 32(5):2253-9. PubMed ID: 25175984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The miR-223 host non-coding transcript linc-223 induces IRF4 expression in acute myeloid leukemia by acting as a competing endogenous RNA.
    Mangiavacchi A; Sorci M; Masciarelli S; Larivera S; Legnini I; Iosue I; Bozzoni I; Fazi F; Fatica A
    Oncotarget; 2016 Sep; 7(37):60155-60168. PubMed ID: 27517498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
    Liang X; Xia R
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inactivation of PTEN increases ABCG2 expression and the side population through the PI3K/Akt pathway in adult acute leukemia.
    Huang FF; Wu DS; Zhang L; Yu YH; Yuan XY; Li WJ; Chen XP; Zhao XL; Chen FP; Zeng H
    Cancer Lett; 2013 Aug; 336(1):96-105. PubMed ID: 23603434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bone marrow stromal cells protect acute myeloid leukemia cells from anti-CD44 therapy partly through regulating PI3K/Akt-p27(Kip1) axis.
    Chen P; Huang H; Wu J; Lu R; Wu Y; Jiang X; Yuan Q; Chen Y
    Mol Carcinog; 2015 Dec; 54(12):1678-85. PubMed ID: 25408361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The PI3K/mTOR dual inhibitor BEZ235 suppresses proliferation and migration and reverses multidrug resistance in acute myeloid leukemia.
    Deng L; Jiang L; Lin XH; Tseng KF; Liu Y; Zhang X; Dong RH; Lu ZG; Wang XJ
    Acta Pharmacol Sin; 2017 Mar; 38(3):382-391. PubMed ID: 28042875
    [TBL] [Abstract][Full Text] [Related]  

  • 48. miR-183-5p Inhibits Occurrence and Progression of Acute Myeloid Leukemia via Targeting Erbin.
    Zheng Z; Zheng X; Zhu Y; Gu X; Gu W; Xie X; Hu W; Jiang J
    Mol Ther; 2019 Mar; 27(3):542-558. PubMed ID: 30799283
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
    Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
    J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
    Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
    Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
    [TBL] [Abstract][Full Text] [Related]  

  • 51. ID4 methylation predicts high risk of leukemic transformation in patients with myelodysplastic syndrome.
    Wang H; Wang XQ; Xu XP; Lin GW
    Leuk Res; 2010 May; 34(5):598-604. PubMed ID: 19853913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [ID4 promoter methylation in acute myeloid leukemia].
    Xu RR; Liu F; Cui X; Zhang XW; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):582-4. PubMed ID: 21729527
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeted inhibition of cooperative mutation- and therapy-induced AKT activation in AML effectively enhances response to chemotherapy.
    Estruch M; Reckzeh K; Vittori C; Centio A; Ali M; Engelhard S; Zhao L; Won KJ; Liu P; Porse BT; Theilgaard-Mönch K
    Leukemia; 2021 Jul; 35(7):2030-2042. PubMed ID: 33299144
    [TBL] [Abstract][Full Text] [Related]  

  • 54. microRNA-126 targeting PIK3R2 promotes rheumatoid arthritis synovial fibro-blasts proliferation and resistance to apoptosis by regulating PI3K/AKT pathway.
    Gao J; Zhou XL; Kong RN; Ji LM; He LL; Zhao DB
    Exp Mol Pathol; 2016 Feb; 100(1):192-8. PubMed ID: 26723864
    [TBL] [Abstract][Full Text] [Related]  

  • 55. microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling.
    Wang L; Zhang H; Lei D
    Yonsei Med J; 2019 Oct; 60(10):924-934. PubMed ID: 31538427
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Semaphorin 4D is a potential biomarker in pediatric leukemia and promotes leukemogenesis by activating PI3K/AKT and ERK signaling pathways.
    Jiang H; Tang J; Qiu L; Zhang Z; Shi S; Xue L; Kui L; Huang T; Nan W; Zhou B; Zhao C; Yu M; Sun Q
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Methylation of Id4 gene promoter in acute leukemia].
    Zhao Y; Wang QS; Dou LP; Bo J; Li HH; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1156-60. PubMed ID: 18088456
    [TBL] [Abstract][Full Text] [Related]  

  • 58. SEMA4D/PlexinB1 promotes AML progression via activation of PI3K/Akt signaling.
    Liu L; Yang L; Liu X; Liu M; Liu J; Feng X; Nie Z; Luo J
    J Transl Med; 2022 Jul; 20(1):304. PubMed ID: 35794581
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SPRY1 promotes cell proliferation and inhibits apoptosis by activating Hedgehog pathway in acute myeloid leukemia.
    Lv G; Wang Y; Ji C; Shi C; Li Y
    Hematology; 2022 Dec; 27(1):1-10. PubMed ID: 34957932
    [TBL] [Abstract][Full Text] [Related]  

  • 60. microRNA-126 inhibits tube formation of HUVECs by interacting with EGFL7 and down-regulating PI3K/AKT signaling pathway.
    Li Q; Cheng K; Wang AY; Xu QG; Fu ZF; He SY; Xu PX
    Biomed Pharmacother; 2019 Aug; 116():109007. PubMed ID: 31170663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.